Yıl: 2020 Cilt: 17 Sayı: 5 Sayfa Aralığı: 535 - 541 Metin Dili: İngilizce DOI: 10.4274/tjps.galenos.2019.82335 İndeks Tarihi: 11-05-2021

Determination of the Physicochemical Properties of Piroxicam

Öz:
Objectives: The aim of this study was to determine the acid dissociation constant (pKa) of piroxicam using high performance liquid chromatography (HPLC) and ultraviolet-visible (UV-Vis) spectrophotometry, and to determine the partition coefficient (Log P), distribution coefficient (Log D), and “Log kw” values of piroxicam using HPLC. Materials and Methods: The HPLC studies were performed on a reversed-phase ACE C18 (150x4.6 mm ID, 5 μm) column at a flow rate of 1.0 mL min-1. The detector was set to 360 nm. Log D at different pH values (3.0-6.5) was examined with a phosphate buffer (20 mM) and acetonitrile (30:70 v/v) mixture as the mobile phase. For pKa determination, HPLC studies were performed with a mixture of phosphate buffer (20 mM) and methanol within the pH range of 3.50-6.00. Log kw measurements were performed with phosphate buffer (20 mM) and MeOH (from 20:80 v/v to 10:90 v/v) mixtures within the pH range of 3.50-6.00. UV-Vis spectrophotometric pKa measurements were performed at 285 nm wavelength. Results: The pKa value of piroxicam was found to be 5.3 by HPLC and 5.7 by UV-Vis spectrophotometry. Log P of piroxicam was determined as 1.58 in our experimental conditions. Log D values were 1.57, 1.57, 1.44, 1.13, and 0.46 for pH values of 3.17, 3.79, 4.44, 5.42, and 6.56, respectively. Conclusion: In the literature, different Log P (3.1, 2.2, and 0.6) and pKa (6.3 and 4.8) values were reported for piroxicam. The Log P (1.58) and pKa (5.3 and 5.7) values obtained for piroxicam in our study were within the range of the literature values. All these results indicate that different experimental approaches used for the determination of physicochemical properties could provide different values. Although UV spectrophotometry is easy to apply, HPLC is a unique technique for simultaneous determination of pKa, Log D, and Log P values of compounds.
Anahtar Kelime:

Piroksikamın Fizikokimyasal Özelliklerinin Belirlenmesi

Öz:
Amaç: Bu çalışmanın amacı, yüksek performanslı sıvı kromatografisi (HPLC) ve ultraviyole-görünür bölge (UV-GB) spektrofotometresi kullanılarak piroksikamın asit ayrışma sabitinin (pKa) bulunması; HPLC kullanılarak partisyon katsayısı (Log P), dağılım katsayısı (Log D) ve “Log kw” değerlerininin belirlenmesidir.Gereç ve Yöntemler: HPLC çalışmaları, 1,0 mL min-1 akış hızında ters faz kromatografisinde ACE C18 (150x4,6 mm ID, 5 μm) kolon kullanılarak gerçekleştirildi. Detektör 360 nm’ye ayarlandı. Farklı pH değerlerinde (3,0-6,5) Log D değeri, hareketli faz olarak fosfat tamponu (20 mM): asetonitril (30:70 h/h) karışımı ile incelendi. pKa’nın belirlenmesi için HPLC çalışmaları, 3,50 ve 6,00 pH aralığında fosfat tamponu (20 mM): metanol karışımı ile gerçekleştirildi. Log kw ölçümleri, pH 3,50 ila 6,00 arasında bir pH aralığında fosfat tamponu (20 mM): MeOH (20:80 h/h ile 10:90 h/h) karışımları ile yapıldı. UV-GB spektrofotometrik pKa ölçümleri 285 nm dalga boyunda gerçekleştirildi.Bulgular: Piroksikamın pKa değeri sırasıyla HPLC ile 5,3 ve UV-GB spektrofotometresi ile 5,7 olarak bulundu. Deney şartlarımızda piroksikamın Log P değeri 1,58 olarak bulundu. Log D değerleri, sırasıyla 3,17, 3,79, 4,44, 5,42 ve 6,56 pH değerleri için 1,57, 1,57, 1,44, 1,13 ve 0,46 olarak bulundu.Sonuç: Literatürde, piroksikam için farklı Log P (3,1, 2,2 ve 0,6) ve pKa (6,3 ve 4,8) değerleri bildirilmiştir. Çalışmamızda piroksikam için elde edilen Log P (1,58) ve pKa (5,3 ve 5,7) değerleri literatür değerleri arasındaydı. Tüm bu sonuçlar, fizikokimyasal özelliklerin belirlenmesinde kullanılan farklı deneysel yaklaşımların farklı değerler verebileceğini göstermektedir. UV spektrofotometresinin uygulanması kolay olsa da, HPLC, bileşiklerin pKa, Log D ve Log P değerlerinin eşzamanlı olarak belirlenmesi için eşsiz tekniklerden biridir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123-133.
  • 2. Hörter D, Dressman J. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev. 2001;46:75-87.
  • 3. Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15(Suppl 3):S2.
  • 4. Simon LS. Nonsteroidal anti-inflammatory drugs and their risk: a story still in development. Arthritis Res Ther. 2013;15(Suppl 3):S1.
  • 5. Cha YI, DuBois RN. NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med. 2007;58:239-252.
  • 6. Portenoy RK, Lesage P. Management of cancer pain. The Lancet. 1999;353:1695-1700.
  • 7. Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis J, Lau J. Evidence report on the treatment of pain in cancer patients. JNCI Monographs. 2004;32:23-31.
  • 8. Rainsford KD, Velo GP. Side-effects of anti-inflammatory drugs: part two studies in major organ systems: Springer Science & Business Media; 2012.
  • 9. Franz CC, Egger S, Born C, Bravo AER, Krähenbühl S. Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis. Eur J Clin Pharmacol. 2012;68:179-188.
  • 10. Dressman J, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Eur J Clin Pharmacol. 2007;59:591-602.
  • 11. Uhrova M, Miksik I, Deyl Z, Bellini S. Determination of dissociation constants by separation methods (HPLC and CE). Theoretical background and guidelines for application. Process Contr Qual. 1997;10:151-167.
  • 12. Oumada FZ, Rafols C, Roses M, Bosch E. Chromatographic determination of aqueous dissociation constants of some water-insoluble nonsteroidal antiinflammatory drugs. J Pharm Sci. 2002;91:991-999.
  • 13. Demiralay EC, Koc D, Daldal YD, Çakır C. Determination of chromatographic and spectrophotometric dissociation constants of some beta lactam antibiotics. J Pharmaceut Biomed. 2012;71:139-143.
  • 14. Canbay HS, Demiralay EC, Alsancak G, Ozkan SA. Chromatographic Determination of pK(a) Values of Some Water-Insoluble Arylpropionic Acids and Arylacetic Acids in Acetonitrile plus Water Media. J Chem Eng Data. 2011;56:2071-2076.
  • 15. Santos E, Rosillo I, Delcastillo B, Avendano C. Determination of Pka Values for Hydantoins by Spectrophotometry. J Chem Res-S. 1982:131.
  • 16. Rosenberg LS, Simons J, Schulman SG. Determination of Pka Values of N-Heterocyclic Bases by Fluorescence Spectrophotometry. Talanta. 1979;26:867-871.
  • 17. Pereira AV, Garabeli AA, Schunemann GD, Borck PC. Determination of Dissociation Constant (K-a) of Captopril and Nimesulide - Analytical Chemistry Experiments for Undergraduate Pharmacy. Quim Nova. 2011;34:1656-1660.
  • 18. Fu XF, Liu Y, Li W, Bai Y, Liao YP, Liu HW. Determination of dissociation constants of aristolochic acid I and II by capillary electrophoresis with carboxymethyl chitosan-coated capillary. Talanta. 2011;85:813-815.
  • 19. Ehala S, Misek J, Stara IG, Stary I, Kasicka V. Determination of acid-base dissociation constants of azahelicenes by capillary zone electrophoresis. J Sep Sci. 2008;31:2686-2893.
  • 20. Schurman H, Thun H, Verbeek F. Potentiometric Determination of Dissociation Constants of Itaconic Acid. J Electroanal Chem. 1970;26:299-305.
  • 21. Qiang ZM, Adams C. Potentiometric determination of acid dissociation constants (pK(a)) for human and veterinary antibiotics. Water Res. 2004;38:2874-2890.
  • 22. Roda G, Dallanoce C, Grazioso G, Liberti V, De Amici M. Determination of Acid Dissociation Constants of Compounds Active at Neuronal Nicotinic Acetylcholine Receptors by Means of Electrophoretic and Potentiometric Techniques. Anal Sci. 2010;26:51-54.
  • 23. Mirrlees MS, Moulton SJ, Murphy CT, Taylor PJ. Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography. J Med Chem. 1976;19:615-619.
  • 24. Haky JE, Young AM. Evaluation of a simple HPLC correlation method for the estimation of the octanol-water partition coefficients of organic compounds. J Liq Chromatogr. 1984;7:675-689.
  • 25. Kaliszan R, Haber P, Baczek T, Siluk D. Gradient HPLC in the determination of drug lipophilicity and acidity. Pure Appl Chem. 2001;73:1465-1475.
  • 26. Yamana T, Tsuji A, Miyamoto E, Kubo O. Novel method for determination of partition coefficients of penicillins and cephalosporins by high‐pressure liquid chromatography. J Pharm Sci. 1977;66:747-749.
  • 27. Wiczling P, Kawczak P, Nasal A, Kaliszan R. Simultaneous determination of p K a and lipophilicity by gradient RP HPLC. Anal Chem. 2006;78:239-249.
  • 28. Singh S, Sharda N, Mahajan L. Spectrophotometric determination of nimesulide through ion-pair complex formation with hexadecyltrimethylammonium bromide. Int J Pharm. 1999;176:261-264.
  • 29. Völgyi G, Ruiz R, Box K, Comer J, Bosch E, Takács-Novák K. Potentiometric and spectrophotometric pKa determination of water-insoluble compounds: validation study in a new cosolvent system. Anal Chim Acta. 2007;583:418-428.
  • 30. Cleveland Jr J, Benko M, Gluck S, Walbroehl Y. Automated p< i> K</i>< sub> a</sub> determination at low solute concentrations by capillary electrophoresis. J Chromatogr A. 1993;652:301-308.
  • 31. Hong H, Wang L, Zou G. Retention in RP-HPLC: Lipophilicity determination of substituted biphenyls by reversed-phase high performance liquid chromatography. J Liq Chromatogr Relat Technol. 1997;20:3029-3037.
  • 32. Markuszewski MJ, Wiczling P, Kaliszan R. High-throughput evaluation of lipophilicity and acidity by new gradient HPLC methods. Comb Chem High Throughput Screen. 2004;7:281-289.
  • 33. Kocak E, Celebier M, Altinoz S. Validation of spectrophotometric method to quantify varenicline content in tablets. Asian J Chem. 2013;25:1845-1848.
  • 34. Braumann T. Determination of hydrophobic parameters by reversed-phase liquid chromatography: theory, experimental techniques, and application in studies on quantitative structure-activity relationships. J Chromatogr A. 1986;373:191-225.
  • 35. Celik H, Buyukaga M, Celebier M, Turkoz Acar E, Baymak MS, Gokhan-Kelekci N, Palaska E, Erdoğan H. Determination of pKa values of some benzoxazoline derivatives and the structure-activity relationship. J Chem Eng Data. 2013;58:1589-1596.
  • 36. Demiralay EC, Alsancak G, Ozkan SA. Determination of pKa values of nonsteroidal antiinflammatory drug-oxicams by RP-HPLC and their analysis in pharmaceutical dosage forms. J Sep Sci. 2009;32:2928-2936.
  • 37. Wiczling P, Kawczak P, Nasal A, Kaliszan R. Simultaneous determination of pKa and lipophilicity by gradient RP HPLC. Anal Chem. 2006;78:239-249.
  • 38. Royal Society of Chemistry, Learn Chemistry, Partition and distribution coefficients Available from: http://www.rsc.org/learn-chemistry/resource/
APA Çelebier M, Nenni M, KAPLAN O, akgeyik e, KAYNAK M, Sahin S (2020). Determination of the Physicochemical Properties of Piroxicam. , 535 - 541. 10.4274/tjps.galenos.2019.82335
Chicago Çelebier Mustafa,Nenni Merve,KAPLAN OZAN,akgeyik emrah,KAYNAK Mustafa Sinan,Sahin Selma Determination of the Physicochemical Properties of Piroxicam. (2020): 535 - 541. 10.4274/tjps.galenos.2019.82335
MLA Çelebier Mustafa,Nenni Merve,KAPLAN OZAN,akgeyik emrah,KAYNAK Mustafa Sinan,Sahin Selma Determination of the Physicochemical Properties of Piroxicam. , 2020, ss.535 - 541. 10.4274/tjps.galenos.2019.82335
AMA Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S Determination of the Physicochemical Properties of Piroxicam. . 2020; 535 - 541. 10.4274/tjps.galenos.2019.82335
Vancouver Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S Determination of the Physicochemical Properties of Piroxicam. . 2020; 535 - 541. 10.4274/tjps.galenos.2019.82335
IEEE Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S "Determination of the Physicochemical Properties of Piroxicam." , ss.535 - 541, 2020. 10.4274/tjps.galenos.2019.82335
ISNAD Çelebier, Mustafa vd. "Determination of the Physicochemical Properties of Piroxicam". (2020), 535-541. https://doi.org/10.4274/tjps.galenos.2019.82335
APA Çelebier M, Nenni M, KAPLAN O, akgeyik e, KAYNAK M, Sahin S (2020). Determination of the Physicochemical Properties of Piroxicam. Turkish Journal of Pharmaceutical Sciences, 17(5), 535 - 541. 10.4274/tjps.galenos.2019.82335
Chicago Çelebier Mustafa,Nenni Merve,KAPLAN OZAN,akgeyik emrah,KAYNAK Mustafa Sinan,Sahin Selma Determination of the Physicochemical Properties of Piroxicam. Turkish Journal of Pharmaceutical Sciences 17, no.5 (2020): 535 - 541. 10.4274/tjps.galenos.2019.82335
MLA Çelebier Mustafa,Nenni Merve,KAPLAN OZAN,akgeyik emrah,KAYNAK Mustafa Sinan,Sahin Selma Determination of the Physicochemical Properties of Piroxicam. Turkish Journal of Pharmaceutical Sciences, vol.17, no.5, 2020, ss.535 - 541. 10.4274/tjps.galenos.2019.82335
AMA Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S Determination of the Physicochemical Properties of Piroxicam. Turkish Journal of Pharmaceutical Sciences. 2020; 17(5): 535 - 541. 10.4274/tjps.galenos.2019.82335
Vancouver Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S Determination of the Physicochemical Properties of Piroxicam. Turkish Journal of Pharmaceutical Sciences. 2020; 17(5): 535 - 541. 10.4274/tjps.galenos.2019.82335
IEEE Çelebier M,Nenni M,KAPLAN O,akgeyik e,KAYNAK M,Sahin S "Determination of the Physicochemical Properties of Piroxicam." Turkish Journal of Pharmaceutical Sciences, 17, ss.535 - 541, 2020. 10.4274/tjps.galenos.2019.82335
ISNAD Çelebier, Mustafa vd. "Determination of the Physicochemical Properties of Piroxicam". Turkish Journal of Pharmaceutical Sciences 17/5 (2020), 535-541. https://doi.org/10.4274/tjps.galenos.2019.82335